Literature DB >> 31270505

Programmable bacteria as cancer therapy.

Michael Dougan1,2, Stephanie K Dougan3,4.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31270505     DOI: 10.1038/s41591-019-0513-4

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

1.  Intratumoral injection of schwannoma with attenuated Salmonella typhimurium induces antitumor immunity and controls tumor growth.

Authors:  Sherif G Ahmed; Giulia Oliva; Manlin Shao; Xinhui Wang; John J Mekalanos; Gary J Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-08       Impact factor: 12.779

2.  Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria.

Authors:  Wenguang Wang; Haiheng Xu; Qingsong Ye; Feng Tao; Ian Wheeldon; Ahu Yuan; Yiqiao Hu; Jinhui Wu
Journal:  Nat Biomed Eng       Date:  2022-01-20       Impact factor: 29.234

Review 3.  Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy.

Authors:  Kumar Ganesan; Songhe Guo; Sundaz Fayyaz; Ge Zhang; Baojun Xu
Journal:  Cancers (Basel)       Date:  2019-10-18       Impact factor: 6.639

Review 4.  Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment.

Authors:  Shruti S Sawant; Suyash M Patil; Vivek Gupta; Nitesh K Kunda
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

5.  Yeast-derived nanoparticles remodel the immunosuppressive microenvironment in tumor and tumor-draining lymph nodes to suppress tumor growth.

Authors:  Jialu Xu; Qingle Ma; Yue Zhang; Ziying Fei; Yifei Sun; Qin Fan; Bo Liu; Jinyu Bai; Yue Yu; Jianhong Chu; Jingrun Chen; Chao Wang
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 17.694

Review 6.  The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?

Authors:  Jiayao Ma; Lingjuan Huang; Die Hu; Shan Zeng; Ying Han; Hong Shen
Journal:  J Exp Clin Cancer Res       Date:  2021-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.